Effect of vancomycin on the proteome of the multiresistant Enterococcus faecium SU18 strain

S. Ramos, I. Chafsey, N. Silva, Michel Hébraud, H. Santos, J. L. Capelo-Martinez, Patricia Poeta, Gilberto Igrejas

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Enterococci are not highly pathogenic bacteria, but the incidence of vancomycin resistance among clinical isolates of this microbial group is steadily increasing, posing a threat to public health. Vancomycin-resistant enterococci are currently some of the most recalcitrant hospital-associated pathogens against which new therapies are urgently needed. To understand the molecular mechanisms of bacterial resistance to glycopeptides, we obtained proteomic profiles of the vancomycin-resistant Enterococcus faecium SU18 strain treated with and without vancomycin. Fourteen proteins were differentially expressed in SU18, seven of which were up-regulated and seven down-regulated. Proteins involved in the vancomycin resistance mechanism, such as the VanA protein, VanA ligase, VanR and D-Ala-D-Ala dipeptidase, were up-regulated in the presence of vancomycin, while metabolism-related proteins, such as triosephosphate isomerase, guanine monophosphate synthase and glyceraldehyde-3-phosphate dehydrogenase were down-regulated. Overall the compensatory response of SU18 to antibiotics is to alter expression of proteins related to antibiotic resistance, cell wall formation and energy metabolism. Some of the differentially expressed proteins might enhance antimicrobial activity and are now being investigated as potential therapeutic drug targets in other pathogenic bacteria. Biological significance: This study highlights the power of proteomics in the study of differential protein expression in a multiresistant Enterococcus faecium strain when subjected to vancomycin stress. © 2014 Elsevier B.V.
Original languageEnglish
Pages (from-to)378-387
Number of pages10
JournalJournal of Proteomics
Volume113
DOIs
Publication statusPublished - 2015

Fingerprint

Enterococcus faecium
Proteome
Vancomycin
Proteins
Vancomycin Resistance
Proteomics
Bacteria
Triose-Phosphate Isomerase
Anti-Bacterial Agents
Glyceraldehyde-3-Phosphate Dehydrogenases
Glycopeptides
Enterococcus
Guanine
Public health
Pathogens
Ligases
Microbial Drug Resistance
Metabolism
Cell Wall
Energy Metabolism

Keywords

  • Antibiotic resistance
  • Enterococcus faecium
  • Proteomic
  • Vancomycin-resistant enterococci
  • bacterial protein
  • dextro alanine dextro alanine dipeptidase
  • dipeptidase
  • glyceraldehyde 3 phosphate dehydrogenase
  • guanine monophosphate synthase
  • protein VanA
  • protein VanR
  • proteome
  • triosephosphate isomerase
  • unclassified drug
  • vancomycin
  • antiinfective agent
  • Article
  • bacterial strain
  • controlled study
  • down regulation
  • energy metabolism
  • multidrug resistance
  • nonhuman
  • nucleotide sequence
  • protein expression
  • proteomics
  • upregulation
  • vancomycin resistant Enterococcus
  • biosynthesis
  • drug effects
  • gene expression regulation
  • genetics
  • metabolism
  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Drug Resistance, Multiple, Bacterial
  • Gene Expression Regulation, Bacterial
  • Proteome
  • Vancomycin

Cite this

Ramos, S. ; Chafsey, I. ; Silva, N. ; Hébraud, Michel ; Santos, H. ; Capelo-Martinez, J. L. ; Poeta, Patricia ; Igrejas, Gilberto. / Effect of vancomycin on the proteome of the multiresistant Enterococcus faecium SU18 strain. In: Journal of Proteomics. 2015 ; Vol. 113. pp. 378-387.
@article{6c3dc3c7f0cb4fc38930ed7641e139c9,
title = "Effect of vancomycin on the proteome of the multiresistant Enterococcus faecium SU18 strain",
abstract = "Enterococci are not highly pathogenic bacteria, but the incidence of vancomycin resistance among clinical isolates of this microbial group is steadily increasing, posing a threat to public health. Vancomycin-resistant enterococci are currently some of the most recalcitrant hospital-associated pathogens against which new therapies are urgently needed. To understand the molecular mechanisms of bacterial resistance to glycopeptides, we obtained proteomic profiles of the vancomycin-resistant Enterococcus faecium SU18 strain treated with and without vancomycin. Fourteen proteins were differentially expressed in SU18, seven of which were up-regulated and seven down-regulated. Proteins involved in the vancomycin resistance mechanism, such as the VanA protein, VanA ligase, VanR and D-Ala-D-Ala dipeptidase, were up-regulated in the presence of vancomycin, while metabolism-related proteins, such as triosephosphate isomerase, guanine monophosphate synthase and glyceraldehyde-3-phosphate dehydrogenase were down-regulated. Overall the compensatory response of SU18 to antibiotics is to alter expression of proteins related to antibiotic resistance, cell wall formation and energy metabolism. Some of the differentially expressed proteins might enhance antimicrobial activity and are now being investigated as potential therapeutic drug targets in other pathogenic bacteria. Biological significance: This study highlights the power of proteomics in the study of differential protein expression in a multiresistant Enterococcus faecium strain when subjected to vancomycin stress. {\circledC} 2014 Elsevier B.V.",
keywords = "Antibiotic resistance, Enterococcus faecium, Proteomic, Vancomycin-resistant enterococci, bacterial protein, dextro alanine dextro alanine dipeptidase, dipeptidase, glyceraldehyde 3 phosphate dehydrogenase, guanine monophosphate synthase, protein VanA, protein VanR, proteome, triosephosphate isomerase, unclassified drug, vancomycin, antiinfective agent, Article, bacterial strain, controlled study, down regulation, energy metabolism, multidrug resistance, nonhuman, nucleotide sequence, protein expression, proteomics, upregulation, vancomycin resistant Enterococcus, biosynthesis, drug effects, gene expression regulation, genetics, metabolism, Anti-Bacterial Agents, Bacterial Proteins, Drug Resistance, Multiple, Bacterial, Gene Expression Regulation, Bacterial, Proteome, Vancomycin",
author = "S. Ramos and I. Chafsey and N. Silva and Michel H{\'e}braud and H. Santos and Capelo-Martinez, {J. L.} and Patricia Poeta and Gilberto Igrejas",
note = "sem pdf conforme despacho. Fundacao para a Ci{\^e}ncia e Tecnologia - SFRH/BD/47706/2008 ; SFRH/BPD17399712010.",
year = "2015",
doi = "10.1016/j.jprot.2014.10.012",
language = "English",
volume = "113",
pages = "378--387",
journal = "Journal of Proteomics",
issn = "1874-3919",
publisher = "Elsevier",

}

Effect of vancomycin on the proteome of the multiresistant Enterococcus faecium SU18 strain. / Ramos, S.; Chafsey, I.; Silva, N.; Hébraud, Michel; Santos, H.; Capelo-Martinez, J. L.; Poeta, Patricia; Igrejas, Gilberto.

In: Journal of Proteomics, Vol. 113, 2015, p. 378-387.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of vancomycin on the proteome of the multiresistant Enterococcus faecium SU18 strain

AU - Ramos, S.

AU - Chafsey, I.

AU - Silva, N.

AU - Hébraud, Michel

AU - Santos, H.

AU - Capelo-Martinez, J. L.

AU - Poeta, Patricia

AU - Igrejas, Gilberto

N1 - sem pdf conforme despacho. Fundacao para a Ciência e Tecnologia - SFRH/BD/47706/2008 ; SFRH/BPD17399712010.

PY - 2015

Y1 - 2015

N2 - Enterococci are not highly pathogenic bacteria, but the incidence of vancomycin resistance among clinical isolates of this microbial group is steadily increasing, posing a threat to public health. Vancomycin-resistant enterococci are currently some of the most recalcitrant hospital-associated pathogens against which new therapies are urgently needed. To understand the molecular mechanisms of bacterial resistance to glycopeptides, we obtained proteomic profiles of the vancomycin-resistant Enterococcus faecium SU18 strain treated with and without vancomycin. Fourteen proteins were differentially expressed in SU18, seven of which were up-regulated and seven down-regulated. Proteins involved in the vancomycin resistance mechanism, such as the VanA protein, VanA ligase, VanR and D-Ala-D-Ala dipeptidase, were up-regulated in the presence of vancomycin, while metabolism-related proteins, such as triosephosphate isomerase, guanine monophosphate synthase and glyceraldehyde-3-phosphate dehydrogenase were down-regulated. Overall the compensatory response of SU18 to antibiotics is to alter expression of proteins related to antibiotic resistance, cell wall formation and energy metabolism. Some of the differentially expressed proteins might enhance antimicrobial activity and are now being investigated as potential therapeutic drug targets in other pathogenic bacteria. Biological significance: This study highlights the power of proteomics in the study of differential protein expression in a multiresistant Enterococcus faecium strain when subjected to vancomycin stress. © 2014 Elsevier B.V.

AB - Enterococci are not highly pathogenic bacteria, but the incidence of vancomycin resistance among clinical isolates of this microbial group is steadily increasing, posing a threat to public health. Vancomycin-resistant enterococci are currently some of the most recalcitrant hospital-associated pathogens against which new therapies are urgently needed. To understand the molecular mechanisms of bacterial resistance to glycopeptides, we obtained proteomic profiles of the vancomycin-resistant Enterococcus faecium SU18 strain treated with and without vancomycin. Fourteen proteins were differentially expressed in SU18, seven of which were up-regulated and seven down-regulated. Proteins involved in the vancomycin resistance mechanism, such as the VanA protein, VanA ligase, VanR and D-Ala-D-Ala dipeptidase, were up-regulated in the presence of vancomycin, while metabolism-related proteins, such as triosephosphate isomerase, guanine monophosphate synthase and glyceraldehyde-3-phosphate dehydrogenase were down-regulated. Overall the compensatory response of SU18 to antibiotics is to alter expression of proteins related to antibiotic resistance, cell wall formation and energy metabolism. Some of the differentially expressed proteins might enhance antimicrobial activity and are now being investigated as potential therapeutic drug targets in other pathogenic bacteria. Biological significance: This study highlights the power of proteomics in the study of differential protein expression in a multiresistant Enterococcus faecium strain when subjected to vancomycin stress. © 2014 Elsevier B.V.

KW - Antibiotic resistance

KW - Enterococcus faecium

KW - Proteomic

KW - Vancomycin-resistant enterococci

KW - bacterial protein

KW - dextro alanine dextro alanine dipeptidase

KW - dipeptidase

KW - glyceraldehyde 3 phosphate dehydrogenase

KW - guanine monophosphate synthase

KW - protein VanA

KW - protein VanR

KW - proteome

KW - triosephosphate isomerase

KW - unclassified drug

KW - vancomycin

KW - antiinfective agent

KW - Article

KW - bacterial strain

KW - controlled study

KW - down regulation

KW - energy metabolism

KW - multidrug resistance

KW - nonhuman

KW - nucleotide sequence

KW - protein expression

KW - proteomics

KW - upregulation

KW - vancomycin resistant Enterococcus

KW - biosynthesis

KW - drug effects

KW - gene expression regulation

KW - genetics

KW - metabolism

KW - Anti-Bacterial Agents

KW - Bacterial Proteins

KW - Drug Resistance, Multiple, Bacterial

KW - Gene Expression Regulation, Bacterial

KW - Proteome

KW - Vancomycin

U2 - 10.1016/j.jprot.2014.10.012

DO - 10.1016/j.jprot.2014.10.012

M3 - Article

VL - 113

SP - 378

EP - 387

JO - Journal of Proteomics

JF - Journal of Proteomics

SN - 1874-3919

ER -